NewLink enters $150M deal to fund cancer therapy work

October 20, 2014 1:09 PM

5 0

An Ames-based pharmaceutical company has entered into a $150 million deal to further develop its cancer therapies.

NewLink Genetics said today that it has entered into an exclusive license agreement with Genentech, a San Francisco-based biotechnology firm.

Also read: Trump gets down to business, prepares to sign order withdrawing US from trade deal

Read more

To category page

Loading...